Castellazzi, M.; Ferri, C.; Piola, A.; Permunian, S.; Buscemi, G.; Laudisi, M.; Baldi, E.; Pugliatti, M.
Dimethyl Fumarate Treatment Reduces the Amount but Not the Avidity of the Epstein–Barr Virus Capsid-Antigen-Specific Antibody Response in Multiple Sclerosis: A Pilot Study. Int. J. Mol. Sci. 2023, 24, 1500.
https://doi.org/10.3390/ijms24021500
AMA Style
Castellazzi M, Ferri C, Piola A, Permunian S, Buscemi G, Laudisi M, Baldi E, Pugliatti M.
Dimethyl Fumarate Treatment Reduces the Amount but Not the Avidity of the Epstein–Barr Virus Capsid-Antigen-Specific Antibody Response in Multiple Sclerosis: A Pilot Study. International Journal of Molecular Sciences. 2023; 24(2):1500.
https://doi.org/10.3390/ijms24021500
Chicago/Turabian Style
Castellazzi, Massimiliano, Caterina Ferri, Alice Piola, Samantha Permunian, Gaia Buscemi, Michele Laudisi, Eleonora Baldi, and Maura Pugliatti.
2023. "Dimethyl Fumarate Treatment Reduces the Amount but Not the Avidity of the Epstein–Barr Virus Capsid-Antigen-Specific Antibody Response in Multiple Sclerosis: A Pilot Study" International Journal of Molecular Sciences 24, no. 2: 1500.
https://doi.org/10.3390/ijms24021500
APA Style
Castellazzi, M., Ferri, C., Piola, A., Permunian, S., Buscemi, G., Laudisi, M., Baldi, E., & Pugliatti, M.
(2023). Dimethyl Fumarate Treatment Reduces the Amount but Not the Avidity of the Epstein–Barr Virus Capsid-Antigen-Specific Antibody Response in Multiple Sclerosis: A Pilot Study. International Journal of Molecular Sciences, 24(2), 1500.
https://doi.org/10.3390/ijms24021500
